SCHEMBL18017556

SCHEMBL18017556

CC(C)CCC(NC(=O)/C(C#N)=C/c1nc(Cl)ccc1Cl)c1ccc(OCCN2CCCCC2)cc1

nearest known ligand 0.75

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP9X Q93008 6/20 0.75
USP24 Q9UPU5 1/20 0.75
HRH3 Q9Y5N1 4/20 0.41
KCNH2 Q12809 1/20 0.41
KMT2A Q03164 3/20 0.40
PSMB1 P20618 1/20 0.40
PSMB5 P28074 1/20 0.40
MEN1 O00255 1/20 0.40
AVPR1B P47901 1/20 0.39
ACACB O00763 1/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
AXL P30530 1/20 0.38
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18017555 0.93 USP9X (0.86) USP9XUSP24HRH3KCNH2KMT2A
SCHEMBL16647252 0.93 USP9X (0.88) USP9XUSP24HRH3KMT2AMEN1
SCHEMBL18017561 0.89 USP9X (0.70) USP9XUSP24HRH3KMT2AKDM4E
SCHEMBL18017557 0.87 USP9X (0.86) USP9XUSP24KMT2AMEN1KDM4E
SCHEMBL16647263 0.86 USP9X (1.00) USP9XUSP24KMT2AMEN1ACACB
SCHEMBL17986430 0.86 USP9X (1.00) USP9XUSP24KMT2AMEN1ACACB
SCHEMBL29376701 0.86 USP9X (1.00) USP9XUSP24KMT2AMEN1ACACB
SCHEMBL18017567 0.85 USP9X (0.74) USP9XUSP24HRH3KMT2AMEN1
SCHEMBL18017565 0.85 USP9X (0.73) USP9XUSP24KMT2AAVPR1BACACB
SCHEMBL16647236 0.82 USP9X (0.82) USP9XUSP24KMT2ACACNA1BAPBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9868736-B2 Deubiquitinase inhibitors and methods for use of the same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-01-16 US disclosed
US-20160237082-A1 DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2016-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160237082-A1 DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME USP1, UCHL1, USP2 USP9X 33/4885USP24 29/4885HRH3 3467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.